SpringWorks Therapeutics Inc (SWTX)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 0 | 0 | 0 | 0 | 0 | 5.45M | 21.01M | 59.73M |
営業利益 | -73.23M | -79.13M | -78.98M | -83.75M | -85.02M | -100.3M | -94.96M | -46.7M |
税引前収入 | -72.39M | -74.18M | -73.42M | -77.93M | -79.44M | -94.32M | -87.39M | -39.92M |
純利益 | -72.39M | -74.18M | -73.42M | -77.93M | -79.44M | -94.32M | -87.39M | -39.92M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -73.3M | -78.98M | -79.18M | -83.85M | -85.1M | -100.3M | -94.96M | -46.7M |
EBITDA | -73.01M | -78.88M | -78.72M | -83.37M | -84.53M | -99.83M | -94.23M | -45.85M |
年末 2023年12月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 35M | 0 | 0 | 5.45M |
営業利益 | -4.66M | -18.49M | -61.85M | -46.93M | -174.46M | -283.56M | -348.05M |
税引前収入 | -4.64M | -17.81M | -58.31M | -45.57M | -173.91M | -277.42M | -325.1M |
純利益 | -4.64M | -17.81M | -50.58M | -45.57M | -173.91M | -277.42M | -325.1M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | -1.023 | -0.825 | -3.123 | -4.029 | -4.71 |
EBIT | -4.66M | -18.49M | -61.85M | -46.9M | -174.61M | -283.7M | -348.05M |
EBITDA | -4.66M | -18.47M | -61.66M | -46.58M | -173.97M | -282.8M | -346.45M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約